4 - 6 Oct • America • Online
Digitalization at Scale: Delivering on the Promise of Science
Days
Hours
Mins
Secs
Life Sciences Summit
Many life sciences companies have experienced growth and are emboldened with stronger balance sheets from which to invest. 2022 will see significant investments in their portfolios, including next generation therapies and investments, to capitalize on their digital progress. With access to a myriad of tools to gather and analyze data, it’s time for life sciences companies to employ digitalization at scale. Everything from research and development (R&D), to commercial processes, to supply chain, to human resources is being reimagined, digitized, and transformed at a pace that we have not seen in years past.
70
Attendees100%
Senior Executives9 Hrs
Industry Insights
Why Attend
To ensure that companies create patient centric products, digital will have to become a strategic priority. More importantly, IT will have to put the end user in mind when enabling and supporting cross functional teams to deliver outcomes that transform the patient health and experience.
Our summits are designed to help you:
Build new connections with likeminded senior leaders
Stay current with emerging business trends
Understand the impact new technology can make
De-risk new projects by gaining a broad range of insights
Accelerate key projects through meaningful new partnerships
Downloadable and actionable takeaways
Event Agenda
Day one
Day two
Day three
09:00 - 09:15
Opening Remarks
Intro & Diamond Commentary
09:15 - 09:45
Keynote
10 years digital acceleration over 18 months: The impact and the journey ahead
Many life sciences companies have experienced growth and are emboldened with stronger balance sheets from which to invest. 2022 will see significant investments in their portfolios, including next generation therapies and investments, to capitalize on their digital progress. With access to a myriad of tools to gather and analyze data, it’s time for life sciences companies to employ digitalization at scale. Everything from research and development (R&D), to commercial processes, to supply chain, to human resources is being reimagined, digitized, and transformed at a pace that we have not seen in years past.
09:45 - 10:25
Panel Discussion
Digitalization at scale: Delivering on the promise of science
What are the key challenges in scaling up emerging technology in the life sciences when considering regulation, privacy and patient protection?
10:25 - 11:15
Roundtables
Track 1: Scaling digital for end-to-end transformation Continued accelerated growth and record investment
Track 2: Enabling technology to get closer to the customer to create personalised experiences
Track 3: Leading a frictionless employee experience to develop critical capabilities and drive innovation
11:15 - 11:27
Insight Break
11:27 - 11:35
Short Break
11:35 - 12:15
Masterclass Breakouts
Track 1: Predictive engagement, using data for personalized experiences
Data without analysis is just ones and zeros. If you’re not looking at the data and acting on that data, it’s useless and has no value. This masterclass will examine innovations using data to improve patient engagement and experiences with leading-edge technology.
Track 2: How to Improve the Automated Customer Experience through Digital-First Engagement
With more and more customers interacting in digital channels – yet still expecting the same level of service they’d get from a human agent – companies have had to quickly adapt a holistic CX approach. The boom in digital-first engagement has been met by a range of sophisticated solutions that allow companies to not just meet these rising customer expectations, but also provide actionable resolutions, even amid major disruptions and changing customer behaviours.
12:17 - 12:47
Headline Keynote
Transforming the patient experience
In life sciences, we have brilliant people. We have technology and deep science. But what we often don’t have, is deep patient insight. We really have an opportunity now to build that in by creating an end-to-end partnership with patients. Digital and data solutions can help embed patient centricity across the value chain. Digital health, medicine, or therapeutic technologies offer many ways to provide value.
09:00 - 09:10
Opening Remarks
09:10 - 09:40
Keynote
Accelerating Productivity: Agility, Analytics and Automation
While COVID-19 has accelerated the growth of digital innovation over the last two years, CEOs remain optimistic that it will continue in the years ahead. But many biopharma executives still believe we need better digital innovation strategy. For a more holistic and enterprise digital transformation (DX) in the life sciences sector, companies must scale digitalization both within the company and outside the organization to produce novel insights through DX partnerships. We need to invest in agility, analytics and automation.
09:42 - 10:22
Panel Discussion
Bringing Enterprise Agility to Scale
Fully transforming and scaling digital requires being agile and adaptable—one of the biggest challenges large, enterprise life sciences and medtech companies are struggling with in 2022. For many, becoming an adaptable organization represents a fundamental shift in operating and management philosophy.
10:22 - 10:32
Insight Break
10:32 - 10:40
Short Break
10:40 - 11:30
Roundtables
Track 1: Scaling digital for end-to-end transformation Continued accelerated growth and record investment
Track 2: Enabling technology to get closer to the customer to create personalised experiences
Track 3: Leading a frictionless employee experience to develop critical capabilities and drive innovation
11:32 - 12:02
Innovation Exchange Keynote
Driving performance while protecting society - a conversation about practicality and ethics in Life science AI
Data has all but transformed the Lifesciences yet what are the implications as more power is given to AI to mine and analyse data?
12:05 - 12:35
Closing Prime Keynote
09:00 - 09:10
Opening Remarks
09:10 - 09:40
Keynote
Workplace Transformation: The future of the Life Sciences digital workplace
As employees and their devices become more distributed, and maximizing productivity depends on enabling work from anywhere operations, the role of IT is fundamentally shifting from that of a mere cost-centre to a critical business partner that enables organizational efficiency and effectiveness. But as employees have become even more dependent on technology for collaboration and getting their jobs done, this new relationship with IT requires a new operational model.
09:45 - 10:25
Panel Discussion
10:27 - 10:37
Insight Break
10:37 - 11:27
Roundtable Leaders Panel
11:27 - 11:35
Short Break
11:37 - 12:07
Innovation Exchange Keynote
Collaboration to drive decisions and performance
Breaking down functional silos to create empowered and accountable multi-disciplinary teams that drive and track investment decisions and performance.
12:10 - 12:45
Closing Keynote
Environmental, Social, and Governance (ESG): A CEO imperative
Life sciences companies face distinct challenges with their very visible role in drug pricing and access to medicines, and the pandemic only underscored this focus. During the pandemic, life sciences companies came closer to their purpose—expanding environmental and diversity/inclusion goals and recommitting to social issues and health equity. ESG (environment, social, and governance) at large is growing in importance as investors, partners, communities, customers, and employees increasingly scrutinize the companies they support. In 2022, ESG performance is expected to come under even more monitoring, and life sciences companies will need to home in on the material factors affecting the sector.
12:45 - 12:55
